How much funding has Cayuga Biotech raised?

Cayuga Biotech has raised $8.0M in total funding, most recently a Seed round.

Who are Cayuga Biotech's investors?

Cayuga Biotech's investors include Wharton Alumni Angels, Gopher Angels, Mass Medical Angels, New York Ventures.

When was Cayuga Biotech founded?

Cayuga Biotech was founded in 2015.

Where is Cayuga Biotech headquartered?

Cayuga Biotech is headquartered in Ithaca, New York, United States.

What industry is Cayuga Biotech in?

Cayuga Biotech operates in Biotech, Healthcare, Medical Devices.

How many employees does Cayuga Biotech have?

Cayuga Biotech has 1-10 employees.

Cayuga Biotech

Ithaca, United States · Founded 2015 · $8.0M raised

Biotech

Healthcare

Medical Devices

Headquarters: Ithaca, New York
Employees: 1–10
Founded: 2015
Business Model: B2B

Website: cayugabiotech.com
Total Funding: $8.0M
Last Round: $8.0M SeedDec 2025
Rounds: 1

About

Cayuga Biotech is a clinical-stage biopharmaceutical company developing novel biomimetic therapies to address life-threatening hemorrhage. Leveraging inorganic polyphosphate, the company's first-in-class therapeutics harness the body's innate ability to stop bleeding, targeting noncompressible hemorrhage, coagulation dysfunction, and bleeding disorders. With over 3.5 million annual treatment opportunities, Cayuga addresses a $25B market.

Summary

Cayuga Biotech is a Biotech company based in Ithaca, United States, founded in 2015. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in Dec 2025. Investors include Wharton Alumni Angels, Gopher Angels and Mass Medical Angels.